Transparency Market Research has published a new report titled "Respiratory Disease Testing Market (By Tests - Imaging, Spirometry, Peak Flow, Blood Gas, Lung Volume, and Other Tests); (By End-User - Hospitals, Physician Offices and Clinical Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022" to its report store.
Albany, NY -- (SBWIRE) -- 05/20/2015 -- Respiratory disease tests are required for the diagnosis of any chronic or acute respiratory disorder. The diagnosis of respiratory function is done either by understanding the anatomy of the respiratory organs, or by determining the respiratory capabilities of the lungs. A majority of respiratory tests are designed either to identify obstructions in the respiratory tract, or to observe the efficiency of the lungs in exchanging respiratory gases. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. This research report on the respiratory disease testing market explains various advancements in this market and analyzes the global respiratory disease testing market based on device type, end-user, and geographic regions. This report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner.
A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global respiratory disease testing market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter's Five Forces analysis and key players' market share analysis in 2013 in the respiratory disease testing market. The research report also provides value chain (distribution) analysis from the supplier of the raw material to the end-users (hospital, physician offices, and clinical laboratories).
For more information, Tables, figures and Segmentation, visit: http://www.transparencymarketresearch.com/respiratory-disease-testing.html
Based on type of test, the global respiratory disease testing market has been segmented into imaging test, spirometry, peak flow test, blood gas test, lung volume test, and other tests. The market for these tests has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each technology has been provided for the period from 2012 to 2022. The report on the respiratory disease testing market also provides % compound annual growth rate (CAGR) for each of the market segment and sub-segment mentioned above for the forecast period from 2014 to 2022, considering 2013 as the base year.
Based on end-user, the global respiratory disease testing market has been segmented into hospitals, physician offices, and clinical laboratories. The market for these end-users of respiratory disease testing has been extensively analyzed based on installation rate and utilization of the devices in hospitals, physician offices, and clinical laboratories. The market size and forecast in terms of USD million for each segment has been provided for the period from 2012 to 2022. The report on the respiratory disease testing market also provides % compound annual growth rate (CAGR) for each market segment and sub-segment for the forecast period from 2014 to 2022, considering 2013 as the base year.
Requesting for sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1288
Geographically, the respiratory disease testing market has been categorized into North America, Europe, Asia-Pacific, Latin America, Middle East North Africa, and Rest of the World (RoW). The market size and forecast for each of these regions have been provided for the period from 2012 to 2022 along with CAGR (%) for the forecast period from 2014 to 2022. The research study also incorporates the competitive scenario of major players in these regions.
A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the respiratory disease testing market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Philips Healthcare, GE Healthcare, CareFusion Corporation, Cosmed, ndd Medical Technologies, Inc., and SDI Diagnostics.
The global respiratory disease testing market is segmented as follows:
Global Respiratory Disease Testing Market, by Test
- Imaging Tests
- Spirometry Tests
- Peak Flow Tests
- Blood Gas Tests
- Lung Volume Tests
- Other Tests
Global Respiratory Disease Testing Market, by End-user
- Physician Offices
- Clinical Laboratories
Global Respiratory Disease Testing Market, by Geography
- Rest of Europe
- Rest of APAC
Latin America (LATAM)
- Rest of LATAM
Middle East North Africa (MENA)
- Saudi Arabia
- Rest of MENA
Rest of the World
About Transparency Market Research
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.